Active	Status	Sponsor type	Region	Phase	Filter
16 Active 0 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chen, Peter V
CATHAY, NCT05562622: Assessment of DOT Spectacles in Chinese Children	Active, not recruiting	N/A	195	RoW	Novel spectacle lens design, Spectacle lenses	SightGlass Vision, Inc.	Juvenile Myopia, Myopia	09/25	03/26
PREDICT, NCT03448926: The Registry:	Recruiting	N/A	3000	US	Treatment Recommendation Surveys, 7-gene biosignature	PreludeDx, University of South Florida	DCIS	12/25	12/35
Thomas, Robert
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia	Completed	3	214	US	Open-label pitolisant, Double-blind placebo, Double-blind pitolisant	Harmony Biosciences, LLC	Idiopathic Hypersomnia	09/23	09/23
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH	Completed	2	50	US	Serdexmethylphenidate, SDX, Placebo	Zevra Therapeutics, Rho, Inc.	Idiopathic Hypersomnia	02/24	03/24
THRIVE, NCT06076499: A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS	Recruiting	N/A	325	US	NTX100	Noctrix Health, Inc.	Restless Legs Syndrome	06/25	12/26